NovoCure Ltd — Director's Dealing 2016

May 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-05-06

Reporting Person: DOYLE WILLIAM F (Director, 10% Owner)
Reporting Person: WFD Ventures Fund II, L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-06	Ordinary Shares	M	8349	$3.59	Acquired	87080	Direct
2016-05-06	Ordinary Shares	F	2381	$12.59	Disposed	84699	Direct
2016-05-06	Ordinary Shares	M	845091	$3.59	Acquired	21619678	Indirect
2016-05-06	Ordinary Shares	F	240976	$12.59	Disposed	21378702	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-06	Warrant	$3.59	M	8349	Disposed	2016-05-08	Ordinary Shares (8349)	Direct
2016-05-06	Warrant	$3.59	M	845091	Disposed	2016-05-08	Ordinary Shares (845091)	Indirect

Footnotes

F1: Mr. Doyle is a managing director of WFD Ventures LLC, the sole member of WFD-GP II, LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle possesses sole voting and investment power over shares owned by WFD Ventures Fund II, L.P. (subject to certain rights of the advisory board of WFD Ventures Fund II, L.P. to approve sales of any of the shares owned by WFD Ventures Fund II, L.P.).

F2: Reflects 2,381 shares withheld by the issuer at the market price of $12.59 per share less an exercise price of $3.59 per share to fund the cashless exercise of 8,349 warrants to purchase ordinary shares owned by Mr. Doyle.

F3: Reflects 240,976 shares withheld by the issuer at the market price of $12.59 per share less an exercise price of $3.59 per share to fund the cashless exercise of 845,091 warrants to purchase ordinary shares indirectly owned by Mr. Doyle.

F4: Exercisable at any time through May 8, 2016.

F5: Includes 78,731 shares previously owned by Mr. Doyle.